Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yea that's my take on it as well. Doesn't look like there's too many shares out there. Chart looking primed for reversal in my opinion.
Same here. Market's been pretty quiet for CYAP up until recent and OTCMarkets shows the OS is only about 20million shares. Could be a fast mover in my opinion
just getting started in my opinion. Bid support building and looking thin through 04 right now
Doesn't look too bad. Also been watching GEQU and CYAP http://bit.ly/1W0CnkZ
Great post. Apps are getting a lot more attention right now and I see no reason why this couldn't go higher. Just my opinion.
HAHA Great point.
I keep buying up all these 1's that this pig seller is dumping. Keep em comin' buddy lol
Yes I saw the same. In any case, I think the interest is growing
Nice close today
There are plenty of buyers and yes this moves quick on the day to day. Once the books are clear of this debt I think all of us longs will be able to see some great rewards. Just my opinion though and this is still the OTC lol.
True. In either case, the chart doesn't look half bad for a solid move in my opinion. It wasn't that long ago when SVACF was in the 20's so I'm hopeful especially if Frost is involved.
CSTI and NITE holding the offer right now. I think if it can push through these, SVACF could see 19/20. Just my opinion
Saw that. Once 19s go. 191's look thin. Hoping to see .20 by next week fingers crossed.
Rate Hike Concerns Have Not Affected These Biotechnology Stocks
CORAL GABLES, FL / ACCESSWIRE / October 15, 2015 / On Wednesday Richmond Federal Reserve President Jeffrey Lacker stated a brief occurrence of upsetting economic information that has done little to alter his outlook for the U.S economy. Lacker, who voted for an interest rate increase in September against the majority of Fed policymakers who choose to keep rates steady, stated he has not decided on how he will vote at the Oct. 27th-28th meeting.
Although he was not persuaded much by a slowdown in job growth and weaker-than-expected retail sales in September, "It doesn't change my outlook much," he told Fox Business in an interview. In contrast to what many had speculated during late September, the space for biotechnology stocks has seen a much more focused approach by investors. Though overall the larger, index driving company stocks have seen consolidation during recent weeks, companies like CASI Pharmaceuticals, Inc. , Alphatec Holdings, Inc., and SciVac Therapeutics Inc. (SVACF) have actually seen an increase in both intra-day prices and comparative volume.
---------
---------
SciVac Therapeutics Inc. (SVACF) whose headquarters are located in Rehovot Israel, is in the business of developing, manufacturing and promoting biological products for human healthcare. The Company's flagship product, Sci-B-Vac(TM), is a recombinant 3rd generation hepatitis B vaccine. SVACF announced recently that its wholly-owned subsidiary SciVac Ltd. has obtained the go-ahead from the Israeli Ministry of Health to progress further on all standard manufacturing involving labeling and release of Sci-B-Vac(TM) to the market. This is after corrective actions were given to the automated labeling system and an overview of the Company's facilities earlier in the month of September. SVACF has seen highs this week of $0.0195, which is up roughly 13% from last Friday's. In previous coverage, it was noted that Opko Health, Inc. (OPKO) had a 45% stake in SciVac. Sci-B-Vac has displaying a performance in 20+ company-sponsored or investigator-initiated trials, dealing with over 5000 who have enrolled while also being administered to over 500,000 patients to date. Results have also been favorable with regard to safety and efficacy profiles according to company data.
http://yhoo.it/1GIvoGm
Trending around the 20MA so far. Needs another catalyst in my opinion. I think it would be good to find out what the current status of everything is after that inspection.
haha. Well one thing's for sure is we should see the actual filing soon that should also give an update to the 3a10 as well. At this pace I think it can be completed before the end of Nov. We will see but at least it's getting a chance to breathe finally
same here. I'm a fan of frost plays especially when I can catch em at a decent bottom price. I payed Actinium too high but I think 19s are a good entry personally
Well said. Also happy to see things turning around here. finally back in the 4s consistently
This has been a great rebound this afternoon. Wouldn't be surprised if this is just the start to the rally.
What's Thursday?
Watch for that squeeze baby, we have others seeing the same thing. CSTI and NITE playing games today. It's gunna hurt for them if this kicks into full short sqeeze mode in my opinion.
Love how NITE is blatantly trying to spark a short here lol.
We're running today! love it
No VFIN anywhere pre market
RXMD monster revs today. BIG NEWS
RXMD game changer: http://yhoo.it/1NabCZ7
"Revenues for the quarter also were the highest since the company's inception. In the third quarter of 2015, the company posted a 14% increase over the same quarter last year at approximately $3.3 million. Through the first nine months of this year the company reached nearly $10 million in revenues, achieved positive cash flow and operating profitability."
This is the tipping point I think. Either validates this whole thing or confirms what all these bashers have been saying. The countdown has begun and i hope the validation is the case.
Hoping this week. Seems to be the trend. Within the first few weeks of the month over the course of the past several months they've put out either a monthly recap or quarterly numbers before the 20th.
Seems like it's getting held back. Chart's been flat since mid August
BMAK is always in the way it seems. My thought is they try to short stocks but can get caught easily on momentum or news days. Look at PNOW, RXMD, and GEQU. Similar reactions to news and trading. All look to me like a strong squeeze play. Just my opinion.
http://bit.ly/1N3o5hi
While people are getting stuck in SAFSD right now, I picked up more RXMD this morning. Hoping to see those earnings soon. Usually drops within the first half of the month and this time it's their quarterly. Fingers crossed they beat last quarter....again lol. Here's a great post on the board of a cliff notes version of the year so far: http://bit.ly/1N3o5hi . Tends to jump on news days